Nanobody
NiV_RBinder_002|Nanobody
Sequence (110 AA)
QVQLQESGGGSVQAGGSLRVSCAASGFTWSSWDDCYWVRQAPGMGLEWVSKEYYYRSSRFTISRDSKKNTVVLQMSSLKPEDTAVYYCASEYMSMAHSWWGQGAQVTVSS
No experimental data
This protein hasn't been validated in the lab yet.
This protein was designed using JORational Antibody-Based Binder Design (RABBD)
Camelid VHH domain; CDR1 Design: Aromatic-rich (W, Y) for specificity; CDR2 Design: Charged residues for salt bridge formation; CDR3 Design: Extended (9 residues) for deep pocket binding; Epitope Target: RBD cavity; Optimization: 10 mutations for novelty; ipSAE Target: >38